Investigation of AKT3 in the resistance of non-small cell lung cancer to EGFR-TKI

被引：0
|
作者：
Huang, Shih-Hsiang [1 ]
Shih, Jin-Yuan [2 ]
Chen, Ching-Chow [1 ]
机构：
[1] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3025
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Role of AKT3 in EGFR-TKI resistance of non-small cell lung cancer.
    Huang, Shih-Hsiang
    Shih, Jin-Yuan
    Chen, Ching-Chow
    [J]. MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 55 - 55
  • [2] Acquired resistance of non-small cell lung cancer to EGFR-TKI: Role of AKT3.
    Huang, Shih-Hsiang
    Shih, Jin-Yuan
    Chen, Ching-Chow
    [J]. CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 55 - 56
  • [3] Apatinib combined with EGFR-TKI in treating advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [4] EGFR-TKI rechallenged treatment combined with apatinib in non-small cell lung cancer with EGFR-TKI resistance.
    Liang, Li
    Li, Fang
    Cao, Baoshan
    Zhang, Zhaohui
    Zhu, Xiang
    Wang, Jiadong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S980 - S981
  • [6] Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer
    Fei Zhou
    Caicun Zhou
    [J]. Oncology and Translational Medicine, 2015, 1 (01) : 20 - 25
  • [7] REBIOPSY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Yamauchi, Hiroyoshi
    Nakayama, Masayuki
    Yamamoto, Shinichi
    Saito, Tatsuya
    Okuyama, Akiko
    Mato, Naoko
    Yamasawa, Hideaki
    Suzuki, Takuji
    Bando, Masashi
    Hagiwara, Koichi
    [J]. RESPIROLOGY, 2017, 22 : 242 - 242
  • [8] Neoadjuvant EGFR-TKI therapy in Non-Small cell lung cancer
    Grant, Christopher
    Nagasaka, Misako
    [J]. CANCER TREATMENT REVIEWS, 2024, 126
  • [9] Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer
    Ko, J.
    Kim, Y.
    Park, M.
    Cui, Z.
    Ahn, M.
    Park, K.
    [J]. EJC SUPPLEMENTS, 2008, 6 (09): : 29 - 30
  • [10] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance (date updated)
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S873 - S873
12345